A histone deacetylase inhibitor enhances killing of undifferentiated thyroid carcinoma cells by p53 gene therapyIMANISHI, Ryo; OHTSURU, Akira; IWAMATSU, Miyoko et al.The Journal of clinical endocrinology and metabolism. 2002, Vol 87, Num 10, pp 4821-4824, issn 0021-972XArticle

Inhibition of nuclear factor-κB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cellsSTARENKI, Dmitriy; NAMBA, Hiroyuki; SAENKO, Vladimir et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 1, pp 410-418, issn 0021-972X, 9 p.Article

Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapyIZUMO, Tsuyoshi; OHTSURU, Akira; TOKUNAGA, Yoshiharu et al.International journal of oncology. 2007, Vol 31, Num 2, pp 379-387, issn 1019-6439, 9 p.Article

BRAF^V600E promotes invasiveness of thyroid cancer cells through nuclear factor κB activationPALONA, Iryna; NAMBA, Hiroyuki; YAMASHITA, Shunichi et al.Endocrinology (Philadelphia). 2006, Vol 147, Num 12, pp 5699-5707, issn 0013-7227, 9 p.Article

Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with PIN1 and aberrant β-catenin expressionNAKASHIMA, Masahiro; MEIRMANOV, Serik; ABROSIMOV, Aleksander et al.Journal of pathology. 2004, Vol 202, Num 4, pp 446-455, issn 0022-3417, 10 p.Article

Novel tumorigenic rearrangement, Δrfp/ret, in a papillary thyroid carcinoma from externally irradiated patientSAENKO, Vladimir; ROGOUNOVITCH, Tatiana; NAMBA, Hiroyuki et al.Mutation research. Fundamental and molecular mechanisms of mutagenesis. 2003, Vol 527, Num 1-2, pp 81-90, issn 1386-1964, 10 p.Article

Aberrant localization of β-catenin correlates with overexpression of its target gene in human papillary thyroid cancerISHIGAKI, Katsu; NAMBA, Hiroyuki; NAKASHIMA, Masahiro et al.The Journal of clinical endocrinology and metabolism. 2002, Vol 87, Num 7, pp 3433-3440, issn 0021-972XArticle

Inhibition of angiogenesis and tumorigenesis, and induction of dormancy by p53 in a p53-null thyroid carcinoma cell line in vivoNAGAYAMA, Yuji; SHIGEMATSU, Kazuto; NAMBA, Hiroyuki et al.Anticancer research. 2000, Vol 20, Num 4, pp 2723-2728, issn 0250-7005Article

Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cellsTAKAKURA, Shu; MITSUTAKE, Norisato; NAKASHIMA, Masahiro et al.Cancer science. 2008, Vol 99, Num 6, pp 1147-1154, issn 1347-9032, 8 p.Article

Characterization of side population in thyroid cancer cell lines : Cancer stem-like cells are enriched partly but not exclusivelyMITSUTAKE, Norisato; IWAO, Atsuhiko; NAGAI, Kazuhiro et al.Endocrinology (Philadelphia). 2007, Vol 148, Num 4, pp 1797-1803, issn 0013-7227, 7 p.Article

Childhood thyroid carcinoma with BRAF^T1799A mutation shows unique pathological features of poor differentiationKUMAGAI, Atsushi; NAMBA, Hiroyuki; MITSUTAKE, Norisato et al.Oncology reports. 2006, Vol 16, Num 1, pp 123-126, issn 1021-335X, 4 p.Article

Large deletions in mitochondrial DNA in radiation-associated human thyroid tumorsROGOUNOVITCH, Tatiana I; SAENKO, Vladimir A; SHIMIZU-YOSHIDA, Yuki et al.Cancer research (Baltimore). 2002, Vol 62, Num 23, pp 7031-7041, issn 0008-5472, 11 p.Article

Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptorISHIHARA, Hiroshi; YOSHIMOTO, Hiroshi; FUJIOKA, Masaki et al.Journal of investigative dermatology. 2000, Vol 115, Num 6, pp 1065-1071, issn 0022-202XArticle

RET oncogene amplification in thyroid cancer : correlations with radiation-associated and high-grade malignancyNAKASHIMA, Masahiro; TAKAMURA, Noboru; NAMBA, Hiroyuki et al.Human pathology. 2007, Vol 38, Num 4, pp 621-628, issn 0046-8177, 8 p.Article

Overexpression of Wild-type THRβ1 Suppresses the Growth and Invasiveness of Human Papillary Thyroid Cancer CellsSEDLIAROU, Ilya; MATSUSE, Michiko; SAENKO, Vladimir et al.Anticancer research. 2007, Vol 27, Num 6B, pp 3999-4009, issn 0250-7005, 11 p.Article

Low frequency of BRAF^T1796A mutations in childhood thyroid carcinomasKUMAGAI, Atsushi; NAMBA, Hiroyuki; THOMAS, Geraldine A et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 9, pp 4280-4284, issn 0021-972X, 5 p.Article

The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinomaSEDLIAROU, Ilya; SAENKO, Vladimir; MINE, Mariko et al.International journal of oncology. 2004, Vol 25, Num 6, pp 1729-1735, issn 1019-6439, 7 p.Article

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancersNAMBA, Hiroyuki; NAKASHIMA, Masahiro; HAYASHI, Tomayoshi et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 9, pp 4393-4397, issn 0021-972X, 5 p.Article

Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-icB Inhibitor, Enhances Antitumor Activity of Taxanes in Anaplastic Thyroid Cancer CellsZHAOWEI MENG; MITSUTAKE, Norisato; YAMASHITA, Shunichi et al.Endocrinology (Philadelphia). 2008, Vol 149, Num 11, pp 5357-5365, issn 0013-7227, 9 p.Article

Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF statusABROSIMOV, Alexander; SAENKO, Vladimir; ROGOUNOVITCH, Tatiana et al.International journal of cancer. 2007, Vol 120, Num 1, pp 196-200, issn 0020-7136, 5 p.Article

TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancerROGOUNOVITCH, Tatiana I; SAENKO, Vladimir A; TCHEBOTAREVA, Irina V et al.Oncology reports. 2006, Vol 15, Num 4, pp 949-956, issn 1021-335X, 8 p.Article

Induction of thyroid cancer cell apoptosis by a novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicinSTARENKI, Dmitriy V; NAMBA, Hiroyuki; SAENKO, Vladimir A et al.Clinical cancer research. 2004, Vol 10, Num 20, pp 6821-6829, issn 1078-0432, 9 p.Article

PKC δ mediates ionizing radiation-induced activation of c-Jun NH₂-terminal kinase through MKK7 in human thyroid cellsMITSUTAKE, Norisato; NAMBA, Hiroyuki; SHKLYAEV, Stanislav S et al.Oncogene (Basingstoke). 2001, Vol 20, Num 8, pp 989-996, issn 0950-9232Article

Involvement of wild-type p53 in radiation-induced c-jun N-terminal kinase activation in human thyroid cellsSHKLYAEV, Stanislav S; NAMBA, Hiroyuki; SAUTIN, Yuriy et al.Anticancer research. 2001, Vol 21, Num 4A, pp 2569-2575, issn 0250-7005Article

Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivoNAGAYAMA, Yuji; YOKOI, Haruhiko; TAKEDA, Katsuo et al.The Journal of clinical endocrinology and metabolism. 2000, Vol 85, Num 11, pp 4081-4086, issn 0021-972XArticle